BridgeBio Oncology Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2023 | — | $-41.7K | $-41.7K |
| FY2024 | — | $-80.9M | $-74.3M |
| FY2025 | — | $-145.8M | $-134.0M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2023 | — | $-41.7K | $-41.7K |
| FY2024 | — | $-80.9M | $-74.3M |
| FY2025 | — | $-145.8M | $-134.0M |